Literature DB >> 17336662

Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - a structural equations modeling approach.

Jochen Schmitt1, Daniel E Ford.   

Abstract

OBJECTIVES: The aim of this study was to assess associations between objective disease severity, psoriasis symptoms, illness-related stress (IRS), health-related quality of life (HRQL) and depressive symptoms in patients with psoriasis.
METHOD: Cross-sectional study conducted between January and May 2005. Recruitment of 265 adult patients with psoriasis through Internet advertisements. Analysis of the validity of different measurement models and the fit of hypothesized structural models using a structural equations modeling approach.
RESULTS: Thirty-two percent of the participants screened positive for depression. Because of poor discriminant validity (correlation: 0.919), IRS and HRQL were considered as one factor. The final measurement model had adequate validity and fit. A significant proportion of the variance of depressive symptoms was explained by HRQL (standardized direct effect: 0.916; P<.001). After adjustment for HRQL, objective severity of psoriasis was inversely related to depressive symptoms (standardized direct effect: -0.250; P=.094).
CONCLUSION: In psoriasis - a condition without direct brain involvement - specific disease-related problems in everyday life seem to cause depression in a significant proportion of patients. It is therefore critically important to regularly assess and work to maximize HRQL in psoriasis patients. Patients with high HRQL impairment despite objectively mild psoriasis should be screened for depression.

Entities:  

Mesh:

Year:  2007        PMID: 17336662     DOI: 10.1016/j.genhosppsych.2006.12.004

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  10 in total

1.  [Depression and anxiety disorders among psoriasis patients: protective and exacerbating factors].

Authors:  K Bangemann; W Schulz; J Wohlleben; A Weyergraf; I Snitjer; T Werfel; G Schmid-Ott; D Böhm
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

Review 2.  The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.

Authors:  Emmilia A Dowlatshahi; Marlies Wakkee; Lidia R Arends; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2013-11-27       Impact factor: 8.551

3.  Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys.

Authors:  Charles G Helmick; Hyewon Lee-Han; Shawn C Hirsch; Tiffany L Baird; Christopher L Bartlett
Journal:  Am J Prev Med       Date:  2014-04-18       Impact factor: 5.043

4.  Psychological Distress, Alexithymia and Alcohol Misuse in Patients with Psoriasis: A Cross-Sectional Study.

Authors:  Ourania Founta; Karoline Adamzik; Anne-Marie Tobin; Brian Kirby; David Hevey
Journal:  J Clin Psychol Med Settings       Date:  2019-06

5.  Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.

Authors:  Yves Poulin; Norman Wasel; Daphne Chan; Geula Bernstein; Robin Andrew; Elisa Fraquelli; Kim Papp
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

6.  Cognitive impairment in patients with severe psoriasis.

Authors:  Luiza Marek-Józefowicz; Marcin Jaracz; Waldemar Placek; Rafał Czajkowski; Alina Borkowska
Journal:  Postepy Dermatol Alergol       Date:  2017-04-13       Impact factor: 1.837

7.  Association of Psoriasis With Anxiety and Depression: A Case-Control Study in Chinese Patients.

Authors:  Danrong Jing; Hui Xiao; Minxue Shen; Xiang Chen; Xi Han; Yehong Kuang; Wu Zhu; Yi Xiao
Journal:  Front Med (Lausanne)       Date:  2021-12-24

8.  Affective temperament, depressive symptoms and interleukins in patients with psoriasis.

Authors:  Luiza Marek-Józefowicz; Marcin Jaracz; Alina Borkowska
Journal:  Postepy Dermatol Alergol       Date:  2021-03-10       Impact factor: 1.837

9.  Anxiety sensitivity and social anxiety in adults with psychodermatological symptoms.

Authors:  Lauren Ellison; Sara M Witcraft; Laura J Dixon
Journal:  Arch Dermatol Res       Date:  2020-08-28       Impact factor: 3.017

10.  Efficacy of psychological intervention for patients with psoriasis vulgaris: a prospective study.

Authors:  Xiaoli Li; Liangliang Liu; Yanfei Zhang; Li Li
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.